INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 416m ago
HOUSE PTR16m ago
SEC 13F16m ago
ROBINHOOD CHAIN15m ago
Corporate insider
LN

Lalwani Nikhil

Director, PRESIDENT & CEOCIK 0001822629

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 3
Max Insider Score22
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
LN
Lalwani NikhilDirector, PRESIDENT & CEO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$388K
5,400 sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ANI PHARMACEUTICALS INCDirector, PRESIDENT & CEO · Feb 13, 2026
22
LN
Lalwani NikhilDirector, PRESIDENT & CEO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL
$383K
5,400 sh
Sep 15, 2026
Sep 16, 2026
traded Sep 15, 2026
+1d
SEC FORM 4

Evidence

16
LN
Lalwani NikhilDirector, PRESIDENT & CEO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$401K
5,400 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

22
LN
Lalwani NikhilDirector, PRESIDENT & CEO
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$2.34M
30.7K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence